Csicsák, D.; Szolláth, R.; Kádár, S.; Ambrus, R.; Bartos, C.; Balogh, E.; Antal, I.; Köteles, I.; Tőzsér, P.; Bárdos, V.;
et al. The Effect of the Particle Size Reduction on the Biorelevant Solubility and Dissolution of Poorly Soluble Drugs with Different Acid-Base Character. Pharmaceutics 2023, 15, 278.
https://doi.org/10.3390/pharmaceutics15010278
AMA Style
Csicsák D, Szolláth R, Kádár S, Ambrus R, Bartos C, Balogh E, Antal I, Köteles I, Tőzsér P, Bárdos V,
et al. The Effect of the Particle Size Reduction on the Biorelevant Solubility and Dissolution of Poorly Soluble Drugs with Different Acid-Base Character. Pharmaceutics. 2023; 15(1):278.
https://doi.org/10.3390/pharmaceutics15010278
Chicago/Turabian Style
Csicsák, Dóra, Rita Szolláth, Szabina Kádár, Rita Ambrus, Csilla Bartos, Emese Balogh, István Antal, István Köteles, Petra Tőzsér, Vivien Bárdos,
and et al. 2023. "The Effect of the Particle Size Reduction on the Biorelevant Solubility and Dissolution of Poorly Soluble Drugs with Different Acid-Base Character" Pharmaceutics 15, no. 1: 278.
https://doi.org/10.3390/pharmaceutics15010278
APA Style
Csicsák, D., Szolláth, R., Kádár, S., Ambrus, R., Bartos, C., Balogh, E., Antal, I., Köteles, I., Tőzsér, P., Bárdos, V., Horváth, P., Borbás, E., Takács-Novák, K., Sinkó, B., & Völgyi, G.
(2023). The Effect of the Particle Size Reduction on the Biorelevant Solubility and Dissolution of Poorly Soluble Drugs with Different Acid-Base Character. Pharmaceutics, 15(1), 278.
https://doi.org/10.3390/pharmaceutics15010278
